The South Korean insurance market operates under a robust dual-tier supervisory system led by the Financial Services Commission (FSC) and the Financial Supervisory Service (FSS). Recent regulatory reforms have focused on enhancing consumer protection and transparency in the sale of complex financial products like critical illness insurance. New "Insurance Sales Commission Reforms" have capped first-year commissions for agents, discouraging "churning" (the practice of convincing clients to switch policies unnecessarily) and encouraging long-term contract retention. These measures are designed to ensure that CI policies are sold based on genuine patient need rather than agent incentives.

The South Korea Critical Illness Insurance Market is also adapting to the implementation of IFRS-17 and the Korea Insurance Capital Standards (K-ICS). These accounting changes require insurers to value their liabilities at current market rates, which has led to a strategic shift away from savings-based products toward protection-type insurance like CI. This regulatory environment favors large, well-capitalized insurers who can maintain high solvency margins while innovating their product offerings. For consumers, these reforms result in a more stable and reliable insurance market where the likelihood of claim fulfillment remains exceptionally high.